OVERVIEW

CANCER blood-scan (CBS) is a research project funded by the “Competitiveness, Entrepreneurship and Innovation” (EPAnEK) Operational Programm with scientific officer Prof. E. Lianidou, Professor of Analytical Chemistry- Clinical Chemistry, Department of Chemistry, EKPA. In the program participate Sub. Prof. A. Psyrri, Attikon Hospital, Medical School, EKPA, Prof. C. Papadimitriou, Aretaio Hospital, Medical School, EKPA, Prof. A. Stratigos, Syggros Hospital, Medical School, EKPA, Prof. S. Kakolyris, Medical School, DUTH, and the PHARMASSIST company. The total budget of the project reaches the amount of EUR 893.058 and its duration will be three years.

The aim of the CANCER blood-scan project is the development and clinical validation of innovative cancer biologic detection methodologies through liquid biopsy. A key goal of this project is to translate the results of basic research into new commercially available products, leading to the application of personalized therapy by liquid biopsy into the clinical routine. To achieve this goal, the research team gathers experts from the academic community, clinical research and the company, contributing to the development and commercialization of in-vitro diagnostic products / kits, with the aim of establishing liquid biopsy in clinical practice.